Skip to main content

Ann Therese Olzinski-Kunze, M.D.

Contact Information

Phone Numbers

Appointment: (585) 487-1700

Office: (585) 273-4702

Fax: (585) 321-1724

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Faculty Appointments

Patient Care Settings

Cancer, Surgery


Professional Background

Dr. Olzinski-Kunze earned her medical degree from the University of Wisconsin-Madison. She then completed her internship and surgical residency at the Medical College of Virginia and the University of Rochester. Following her residency, she completed a fellowship in Breast Surgery here at the University of Rochester.

Dr. Olzinski-Kunze worked as an Attending Surgeon, Instructor of Surgery, and Assistant Professor of Surgery at Strong Memorial Hospital and Highland Hospital from 2004 to 2008. During this time, Dr. Olzinski-Kunze also served on the Strong Memorial Hospital Cancer Committee, from 2006 to 2008.

Now, after working in private practice for several years, Dr. Olzinski-Kunze is returning to UR Medicine. We are pleased to welcome her back to the Department of Surgery and the Wilmot Cancer Institute Comprehensive Breast Care at Pluta program.

Dr. Olzinski-Kunze is board certified by the American Board of Surgery. She is also a member of the American Society of Breast Surgeons. Dr. Olzinski-Kunze has been active in research and has authored and co-authored several publications.


Principal Investigator NSABP B 35: A Clinical Trial Comparing Tamoxifen with Anastrozole in Post-menopausal Patients- currently enrolling.

Principal Investigator ACASOG Z0011: A Randomized Trial of Axillary Node Dissection in Women with T1 or T2 N0M0 Breast Cancer who have a Positive Sentinel Lymph Node- currently in follow up phase.

Principal Investigator ACOSOG Z0010: A Prognostic Study of Sentinel Node and Bone Marrow Micrometastases in Women with Clinical T1 or T2 N0M0 Breast Cancer: currently in follow up phase.

Co-Investigator NSABP B-39/RTOG 0413: Partial Breast Radiation for Patients with Stage 0, 1, or 2 Breast Cancer Resected by Lumpectomy- currently enrolling.

Co-Investigator ACOSOG Z1031: A Randomized Phase III Trial Comparing 16 to 18 Weeks of Neoadjuvant Exemestane, Letrozole, or Anastrozole in Postmenopausal Women with Clinical Stage II and III Estrogen Receptor Positive Breast Cancer- beginning enrollment in 2006.

Co-Investigator Evaluation of the Role of Heat Shock Protein 27 in Breast Cancer- enrolling beginning in 2006




    MD | University of Wisconsin-Madison

    Post-doctoral Training & Residency

    07/01/2004 - 12/31/2004
    Fellowship in Surgery (General Surgery) at University of Rochester Medical Center

    06/30/2001 - 06/30/2004
    Residency in Surgery (General Surgery) at University of Rochester Medical Center

    07/01/1999 - 06/30/2001
    Fellowship in Research at Medical College of Virginia Hospitals

    07/01/1998 - 06/30/2000
    Residency in Surgery (General Surgery) at Medical College of Virginia Hospitals

    07/01/1997 - 06/30/1998
    Internship in Surgery (General Surgery) at Medical College of Virginia Hospitals

    VIEW ALL expand_more


    FELLOWSHIP AWARDS National Institute of Diabetes and Digestive and Kidney Diseases, National Research Service Award 1F32DK10025-01, Medical College of Virginia, 2000, Funding of research related to portal hypertension

    Lucille O'Keefe Parker Scholarship for academic excellence University of Wisconsin Medical School


    At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information.